de Klerk Marry, Kal-van Gestel Judith A, Haase-Kromwijk Bernadette J J M, Claas Frans H J, Weimar Willem
Department of Internal Medicine - Transplantation, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Clin Transpl. 2011:287-90.
In January 2004, the Dutch transplant centers agreed on a protocol for a national Living Donor Kidney Exchange Program for ABO blood type incompatible and positive cross match donor-recipient pairs. Here, we report the results of that program. All transplants performed within the Living Donor Kidney Exchange Program between January 2004 and December 2011 were analysed. We collected demographic data of recipients and donors. Univariate and multivariate Cox proportional hazard analyses were performed, including recipient age, donor age, and reason for participation in the exchange program. We studied overall uncensored survival and graft survival censored for death in both ABO blood type incompatible and positive cross match groups. We enrolled 472 donor-recipient combinations, consisting of 269 ABO blood type incompatible pairs and 203 positive cross match pairs. In the end, we performed 187 kidney transplants (40% of those enrolled) with 83 ABO blood type incompatible and 104 positive cross match pairs. Most of the transplanted recipients (119/187, 64%) had an age difference of less than 5 years with their original incompatible donors. The age differences with their actual donors varied widely, but the number of recipients with a donor > 5 years older was comparable to the number of recipients with a donor > 5 years younger. In the multivariate Cox analysis, age as a continuous variable was found to have a significant influence on graft failure. Nevertheless, the 5-year uncensored survival (85%) and the graft survival censored for death (89%) were excellent and comparable to the results of direct living donation. No differences were found between the ABO incompatible and the positive cross match groups. The Dutch Living Donor Kidney Exchange Program has a high transplant rate of 40%, with excellent 5 year graft survival.
2004年1月,荷兰各移植中心就一项针对ABO血型不相容且交叉配血阳性的供受者对的全国性活体供肾交换计划达成了一项方案。在此,我们报告该计划的结果。对2004年1月至2011年12月期间在活体供肾交换计划内进行的所有移植手术进行了分析。我们收集了受者和供者的人口统计学数据。进行了单变量和多变量Cox比例风险分析,包括受者年龄、供者年龄以及参与交换计划的原因。我们研究了ABO血型不相容组和交叉配血阳性组的总体未删失生存情况以及因死亡而删失的移植物生存情况。我们纳入了472对供受者组合,其中包括269对ABO血型不相容对和203对交叉配血阳性对。最终,我们进行了187例肾移植手术(占纳入病例的40%),其中83对为ABO血型不相容对,104对为交叉配血阳性对。大多数移植受者(119/187,64%)与其最初不相容的供者年龄相差不到5岁。他们与实际供者的年龄差异各不相同,但供者年龄比受者大5岁以上的受者数量与供者年龄比受者小5岁以上的受者数量相当。在多变量Cox分析中,年龄作为连续变量被发现对移植物失败有显著影响。然而,5年未删失生存率(85%)和因死亡而删失的移植物生存率(89%)都非常好,与直接活体捐赠的结果相当。ABO血型不相容组和交叉配血阳性组之间未发现差异。荷兰活体供肾交换计划的移植率高达40%,5年移植物生存率良好。